P.331 - Utility of a next-generation sequencing (NGS)-based neuromuscular disease gene panel in an investigation of 30 families with early-onset presentation from a tertiary pediatric neuromuscular clinic.

Saved in:
Bibliographic Details
Title: P.331 - Utility of a next-generation sequencing (NGS)-based neuromuscular disease gene panel in an investigation of 30 families with early-onset presentation from a tertiary pediatric neuromuscular clinic.
Authors: Ardicli, D.1, Nowak, K.2, Haliloglu, G.1, Goullee, H.3, Davis, M.4, Talim, B.1, Laing, N.5, Topaloğlu, H.1
Source: Neuromuscular Disorders. Oct2017 Supplement 2, Vol. 27, pS196-S196. 1p.
Database: Academic Search Ultimate
Description
ISSN:09608966
DOI:10.1016/j.nmd.2017.06.371